This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kaklamanis, L. Articles by Gatter, K. C. Search for Related Content PubMed PubMed Citation Articles by Kaklamanis, L. Articles by Gatter, K. C.

American Journal of Pathology, Vol 145, 505-509, Copyright © 1994 by American Society for Investigative Pathology

REGULAR ARTICLES

Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer

L Kaklamanis, A Townsend, IA Doussis-Anagnostopoulou, N Mortensen, AL Harris and KC Gatter
Nuffield Department of Pathology, John Radcliffe Hospital, University of Oxford, United Kingdom.

Presentation of endogenous antigenic peptides to cytotoxic T lymphocytes (CTLs) is mediated by the major histocompatibility complex (MHC) class I molecules. These antigenic peptides derived from the cytoplasmic protein pool are transported by the recently described MHC- encoded transporters (TAP1 and TAP2) into a pre-Golgi region where they take part in the assembly of MHC class I molecules. Using an affinity- purified polyclonal antibody (AK1.7) for TAP1, we analyzed 81 colorectal carcinomas, 32 adenomas, and the respective nonneoplastic mucosa. Loss of the transporter molecule (TAP1) was observed in 14% (11 of 81) of the carcinomas, either complete (7 of 11) or focal (4 of 11), whereas adenomas and normal mucosa were always positive. This study adds further information to the understanding of the mechanisms related to the defective presentation of the MHC class I molecules by tumor cells.

This article has been cited by other articles:

				M. Kloor, C. Becker, A. Benner, S. M. Woerner, J. Gebert, S. Ferrone, and M. von Knebel Doeberitz Immunoselective Pressure and Human Leukocyte Antigen Class I Antigen Machinery Defects in Microsatellite Unstable Colorectal Cancers Cancer Res., July 15, 2005; 65(14): 6418 - 6424. [Abstract] [Full Text] [PDF]

				E. Ryschich, T. Notzel, U. Hinz, F. Autschbach, J. Ferguson, I. Simon, J. Weitz, B. Frohlich, E. Klar, M. W. Buchler, et al. Control of T-Cell-Mediated Immune Response by HLA Class I in Human Pancreatic Carcinoma Clin. Cancer Res., January 15, 2005; 11(2): 498 - 504. [Abstract] [Full Text] [PDF]

				M. Vitale, G. Pelusi, B. Taroni, G. Gobbi, C. Micheloni, R. Rezzani, F. Donato, X. Wang, and S. Ferrone HLA Class I Antigen Down-Regulation in Primary Ovary Carcinoma Lesions: Association with Disease Stage Clin. Cancer Res., January 1, 2005; 11(1): 67 - 72. [Abstract] [Full Text] [PDF]

				A. L. Tozzi Spinardi-Barbisan, L. F. Barbisan, J. Lauro Viana De Camargo, and M. Aparecida Marchesan Rodrigues Infiltrating CD8+ T Lymphocytes, Natural Killer Cells, and Expression of IL-10 and TGF-{beta}1 in Chemically Induced Neoplasms in Male Wistar Rats Toxicol Pathol, August 1, 2004; 32(5): 548 - 557. [Abstract] [PDF]

				M. Kurte, M. Lopez, A. Aguirre, A. Escobar, J. C. Aguillon, J. Charo, C. G. Larsen, R. Kiessling, and F. Salazar-Onfray A Synthetic Peptide Homologous to Functional Domain of Human IL-10 Down-Regulates Expression of MHC Class I and Transporter Associated with Antigen Processing 1/2 in Human Melanoma Cells J. Immunol., August 1, 2004; 173(3): 1731 - 1737. [Abstract] [Full Text] [PDF]

				S. Krishnakumar, D. Abhyankar, A. L. Sundaram, V. Pushparaj, M. P. Shanmugam, and J. Biswas Major Histocompatibility Antigens and Antigen-processing Molecules in Uveal Melanoma Clin. Cancer Res., September 15, 2003; 9(11): 4159 - 4164. [Abstract] [Full Text] [PDF]

				A. M. Wolf, D. Wolf, M. Steurer, G. Gastl, E. Gunsilius, and B. Grubeck-Loebenstein Increase of Regulatory T Cells in the Peripheral Blood of Cancer Patients Clin. Cancer Res., February 1, 2003; 9(2): 606 - 612. [Abstract] [Full Text] [PDF]

				B. Lankat-Buttgereit and R. Tampe The Transporter Associated With Antigen Processing: Function and Implications in Human Diseases Physiol Rev, January 1, 2002; 82(1): 187 - 204. [Abstract] [Full Text] [PDF]

				A. K. Johnsen, D. J. Templeton, M.-S. Sy, and C. V. Harding Deficiency of Transporter for Antigen Presentation (TAP) in Tumor Cells Allows Evasion of Immune Surveillance and Increases Tumorigenesis J. Immunol., October 15, 1999; 163(8): 4224 - 4231. [Abstract] [Full Text] [PDF]

				T. Kageshita, S. Hirai, T. Ono, D. J. Hicklin, and S. Ferrone Down-Regulation of HLA Class I Antigen-Processing Molecules in Malignant Melanoma : Association with Disease Progression Am. J. Pathol., March 1, 1999; 154(3): 745 - 754. [Abstract] [Full Text] [PDF]

				S M TODRYK, H CHONG, R G VILE, H PANDHA, and N R LEMOINE Can immunotherapy by gene transfer tip the balance against colorectal cancer? Gut, October 1, 1998; 43(4): 445 - 449. [Abstract] [Full Text] [PDF]